Rallies amid New Phase 3 Study for CagriSema

tipranks.com/news/novo-nordisk-stock-nvo-rallies-amid-new-phase-3-study-for-cagrisema

Shares of Novo Nordisk ($NVO) are rallying in today’s trading after it launched a new Phase 3 trial for its next-generation weight loss drug, Cagri...

This story appeared on tipranks.com, 2025-06-10 18:43:56.
The Entire Business World on a Single Page. Free to Use →